The New England journal of medicine, 2021-05, Vol.384 (18), p.1705-1718
- Dorman, Susan E
- Nahid, Payam
- Kurbatova, Ekaterina V
- Phillips, Patrick P.J
- Bryant, Kia
- Dooley, Kelly E
- Engle, Melissa
- Goldberg, Stefan V
- Phan, Ha T.T
- Hakim, James
- Johnson, John L
- Lourens, Madeleine
- Martinson, Neil A
- Muzanyi, Grace
- Narunsky, Kim
- Nerette, Sandy
- Nguyen, Nhung V
- Pham, Thuong H
- Pierre, Samuel
- Purfield, Anne E
- Samaneka, Wadzanai
- Savic, Radojka M
- Sanne, Ian
- Scott, Nigel A
- Shenje, Justin
- Sizemore, Erin
- Vernon, Andrew
- Waja, Ziyaad
- Weiner, Marc
- Swindells, Susan
- Chaisson, Richard E
2021
Details
- Autor(en) / Beteiligte
- Dorman, Susan E
- Nahid, Payam
- Kurbatova, Ekaterina V
- Phillips, Patrick P.J
- Bryant, Kia
- Dooley, Kelly E
- Engle, Melissa
- Goldberg, Stefan V
- Phan, Ha T.T
- Hakim, James
- Johnson, John L
- Lourens, Madeleine
- Martinson, Neil A
- Muzanyi, Grace
- Narunsky, Kim
- Nerette, Sandy
- Nguyen, Nhung V
- Pham, Thuong H
- Pierre, Samuel
- Purfield, Anne E
- Samaneka, Wadzanai
- Savic, Radojka M
- Sanne, Ian
- Scott, Nigel A
- Shenje, Justin
- Sizemore, Erin
- Vernon, Andrew
- Waja, Ziyaad
- Weiner, Marc
- Swindells, Susan
- Chaisson, Richard E
- Titel
- Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
- Ist Teil von
- The New England journal of medicine, 2021-05, Vol.384 (18), p.1705-1718
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2021
- Link zum Volltext
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In this phase 3 trial for the treatment of tuberculosis, a 4-month rifapentine-based regimen containing moxifloxacin was noninferior to a standard 6-month regimen.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2033400Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8282329
- Format
- –
- Schlagworte
- Acquired immune deficiency syndrome, Adolescent, Adult, Adverse events, AIDS, Antibiotics, Antitubercular - administration & dosage, Antibiotics, Antitubercular - adverse effects, Antitubercular Agents - adverse effects, Antitubercular Agents - therapeutic use, Cavitation, Child, Clinical trials, Confidence Intervals, Consortia, Drug Administration Schedule, Drug dosages, Drug therapy, Drug Therapy, Combination, Ethambutol, Female, Fluoroquinolones, Genomes, HIV, Human immunodeficiency virus, Humans, Isoniazid, Laboratories, Male, Medical research, Medicine, Experimental, Microscopy, Moxifloxacin, Moxifloxacin - administration & dosage, Moxifloxacin - adverse effects, Mycobacterium tuberculosis - isolation & purification, Pyrazinamide, Radiography, Rifampin, Rifampin - administration & dosage, Rifampin - adverse effects, Rifapentine, Sensitivity analysis, Tuberculosis, Tuberculosis, Pulmonary - drug therapy, Young Adult